Navigation Links
Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance
Date:2/22/2011

nted in Japan and Canada and one for the liposomal formulation of TELINTRA granted in Canada. Three other patents covering novel TELINTRA analogs were granted in Singapore and Chile.
  • Publication of a review in the journal, Cell Death and Differentiation: Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. This review describes recent advances in the understanding of the important role that the enzyme GSTP1-1 plays in the progression of cancer and other diseases associated with increased cell proliferation. TELINTRA, inhibitor of GSTP1-1, has recently been reported to show positive results in a Phase 2 trial in patients with MDS, a disease characterized by disordered cell proliferation and differentiation.
  • Publication of a case report by Quddus et al., Oral Ezatiostat Hydrochloride (TELINTRA®) and Myelodysplastic Syndrome (MDS): A case report of sustained hematologic response following an abbreviated exposure Journal of Hematology & Oncology 2010, 3:16. This case report describes a patient who experienced a sustained hematologic response in all three blood cell lines continuing for over a year, after an abbreviated course of oral TELINTRA received while on the current Phase 2 Study in Low to Intermediate-1 Risk MDS.

  • In 2011, Telik is focusing its resources on: (1) advancing the clinical development of TELINTRA in MDS including the completion of the ongoing Phase 1 TELINTRA combination trial with lenalidomide, (2) seeking corporate partnerships for development and commercialization of its drug product candidates, (3) advancing its leading preclinical oncology drug candidates and (4) supporting TRAP® research collaborations.

    Financial Outlook

    For the full year 2011, Telik anticipates total operating costs and expenses to be in the range of $13.0 million to $15.0 million, which includes stock-based compensation expense of approximately $1.3 millio
    '/>"/>

    SOURCE Telik, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
    2. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
    3. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
    4. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
    5. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
    6. Telik Announces Presentation at ASCO Annual Meeting
    7. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
    8. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
    9. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
    10. Telik Announces Third Quarter 2009 Financial Results
    11. Telik Announces Fourth Quarter and 2009 Year End Financial Results and 2010 Financial Guidance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)... it comes to welcoming our new robot overlords, InformationWeek editor ... red carpet. Healthcare is one of the major ... our human sphere. With healthcare concerns top of mind in ... new technologies to help with old problems. That,s where robots ... to increase from $1.7 billion now to $3.7 billion by ...
    (Date:7/23/2014)... MEETING, Pa. , July 23, 2014 ... INO) today announced successful results from its ... VGX-3100 in women with biopsy-proven cervical intraepithelial ... (HPV) types 16 or 18. Treatment with ... regression of CIN2/3 to CIN1 or no ...
    (Date:7/23/2014)... LOS ANGELES , July 23, 2014  Researchers ... supplementing with calcium elevates calcium levels too ... stones, among other health problems. Women close ... calcium and vitamin D to prevent diseases such as ... "I would recommend that women determine how much calcium ...
    Breaking Medicine Technology:Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Women Taking Too Much Calcium Create Health Risk 2
    ... Nov. 8, 2010 GenVec, Inc. (Nasdaq: GNVC ) ... 30, 2010.   GenVec reported a net loss of ... 30, 2010 compared to a net loss of $3.6 million ($0.04 ... months ended September 30, 2010, GenVec,s net loss was $11.3 million ...
    ... 8, 2010 XStor Medical Systems, Inc. announces the ... quality management system certification is a key step in ... globally. "XStor,s software products are designed under ... codifies our ability to deliver safe & effective solutions. ...
    Cached Medicine Technology:GenVec Reports Third Quarter 2010 Financial Results 2GenVec Reports Third Quarter 2010 Financial Results 3GenVec Reports Third Quarter 2010 Financial Results 4GenVec Reports Third Quarter 2010 Financial Results 5
    (Date:7/23/2014)... Recently, iFitDress.com, a professional company of women’s dresses ... vintage party dresses . Aside from that, it has ... is up to 63% off. , “We are excited to ... items are all manufactured by trustworthy and experienced workers in ... 30; it is great to provide such a great opportunity ...
    (Date:7/23/2014)... (PRWEB) July 23, 2014 A new ... a power morcellator ( http://www.injurybeacon.com/power-morcellator/ ) during minimally ... cancers throughout a woman’s body, Bernstein Liebhard LLP reports. ... the Journal of the American Medical Association, looked at ... morcellator at 500 U.S. hospitals from 2006 to 2012. ...
    (Date:7/23/2014)... Steven Reinberg HealthDay Reporter ... obese and overweight American children and teens look in ... U.S. health officials reported Wednesday. "Being overweight or ... high blood pressure, high cholesterol and diabetes," said lead ... Centers for Disease Control and Prevention,s National Center for ...
    (Date:7/23/2014)... (PRWEB) July 23, 2014 Home ... in-home care for seniors, is proud to announce the ... featuring experts in a wide range of health and ... social worker and award-winning author Nancy Kriseman, and will ... ways to prevent burnout by becoming more self-aware. In ...
    (Date:7/23/2014)... body of research suggesting a safe and effective ... breast cancer, with fewer detrimental side effects and ... The study will be published in final format ... and Endocrinology . , Breast cancer is the ... United States. Approximately 70% of breast cancers are ...
    Breaking Medicine News(10 mins):Health News:Cheap 2014 Vintage Party Dresses From Professional Supplier iFitDress.com 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5
    ... News) -- Older women who take nonsteroidal anti-inflammatory drugs -- ... lower risk of death from colorectal cancer than women who ... Women who reported using these drugs, called NSAIDs, at the ... roughly 30 percent lower rate of death from colorectal cancer ...
    ... OCTOBER 24, 2011) Heavy alcohol consumption may be ... while higher BMI and increased consumption of black tea ... deadly disease. In three separate studies presented at CHEST ... of Chest Physicians (ACCP), heavy alcohol consumption was related ...
    ... safe and effective therapy, according to a new long-term ... co-hosted by the Heart and Stroke Foundation and the ... Ottawa Heart Institute heart transplant program revealed results from ... transplant patients. Mean age at transplant was 49 13 ...
    ... Postmenopausal women who reported having used nonsteroidal anti-inflammatory drugs ... enrollment in the Women,s Health Initiative study had a ... women who reported no use of these drugs at ... International Conference on Frontiers in Cancer Prevention Research, held ...
    ... October 23, 2011 -- A new study conducted in an ... called "lazy eye," can be achieved in many older children, ... games along with standard amblyopia treatment. Today at the 115th ... Ghosh will report on the approaches that allowed about a ...
    ... rehabilitation boosts longevity, especially in patients with the lowest ... Cardiovascular Congress 2011, co-hosted by the Heart and Stroke ... benefits to cardiac rehabilitation, regardless of how fit ... cardiac surgery resident and PhD candidate at the University ...
    Cached Medicine News:Health News:Can NSAIDs Cut Colorectal Cancer Deaths in Older Women? 2Health News:Heavy alcohol consumption linked to lung cancer 2Health News:Heart transplant surgery safe and effective: A Canadian retrospective spanning 3 decades 2Health News:Heart transplant surgery safe and effective: A Canadian retrospective spanning 3 decades 3Health News:NSAID use associated with lower colorectal cancer mortality rates among postmenopausal women 2Health News:Video games used in new treatment that may fix 'lazy eye' in older children 2Health News:Rehab helps heart patients live longer -- but they have to show up 2Health News:Rehab helps heart patients live longer -- but they have to show up 3
    ... Ultrapure MB Grade PRODUCT SPECIFICATIONS Form: Granular, free-flowing ... Gel Point (1.5%): 36.0 1.5C Remelt Point ... than or equal to 1,200 gm/cm 2 ... 2,500 gm/cm 2 Moisture: less than or ...
    ... traces: chloride (Cl) ≤ 3000 mg/kg sulfate (SO 4 ... mg/kg Cd ≤ 10 mg/kg Co ≤ 10 mg/kg ... ≤ 10 mg/kg K ≤ 500 mg/kg Mg ≤ ... mg/kg Ni ≤ 10 mg/kg Pb ≤ 10 mg/kg ...
    ... a multipurpose agarose, has been developed for ... and separation of high molecular weight DNA ... a high gel strength agarose ( 1800 ... the use of low concentrations of agarose ...
    Inquire...
    Medicine Products: